NASDAQ:CMPX

Compass Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CMPX

*Your capital is at risk

$2.10

+0.0200 (+0.96%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CMPX Prediction Chart

CMPX Predictions History

Latest community submissions for CMPX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Feb 19, 2025	$3.26 +2.70%	$3.38	V	96.32%	1
labbiel	Feb 19, 2025	$3.46 +9.15%	$3.38	V	97.63%	1
labbiel	Feb 19, 2025	Bullish	$3.38	X	—	1
PredictionBot.Kathy Pro	Feb 5, 2025	$3.00 -3.84%	$3.38	X	88.76%	0
PredictionBot.Warren Pro	Feb 5, 2025	$3.05 -2.40%	$3.38	X	90.09%	0
k29z8w5x7n	Feb 5, 2025	Bullish	$3.38	V	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CMPX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT COMPASS THERAPEUTICS, INC.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trial for colorectal and ovarian cancer; CTX-471, a monoclonal antibody product candidate that i...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by